Back to Journals » International Journal of Nanomedicine » Volume 11

Combination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: an effective anticancer therapy

Authors Zhang X, Gurunathan S

Received 24 April 2016

Accepted for publication 1 June 2016

Published 2 August 2016 Volume 2016:11 Pages 3655—3675

DOI https://doi.org/10.2147/IJN.S111279

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Govarthanan Muthusamy

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Thomas J Webster

Xi-Feng Zhang,1 Sangiliyandi Gurunathan2

1College of Biological and Pharmaceutical Engineering, Wuhan Polytechnic University, Wuhan, People’s Republic of China; 2Department of Stem Cell and Regenerative Biology, Konkuk University, Seoul, South Korea

Abstract: Ovarian cancer is one of the most important malignancies, and the origin, detection, and pathogenesis of epithelial ovarian cancer remain elusive. Although many cancer drugs have been developed to dramatically reduce the size of tumors, most cancers eventually relapse, posing a critical problem to overcome. Hence, it is necessary to identify possible alternative therapeutic approaches to reduce the mortality rate of this devastating disease. To identify alternative approaches, we first synthesized silver nanoparticles (AgNPs) using a novel bacterium called Bacillus clausii. The synthesized AgNPs were homogenous and spherical in shape, with an average size of 16–20 nm, which are known to cause cytotoxicity in various types of human cancer cells, whereas salinomycin (Sal) is able to kill cancer stem cells. Therefore, we selected both Sal and AgNPs to study their combined effect on apoptosis and autophagy in ovarian cancer cells. The cells treated with either Sal or AgNPs showed a dose-dependent effect with inhibitory concentration (IC)-50 values of 6.0 µM and 8 µg/mL for Sal and AgNPs, respectively. To determine the combination effect, we measured the IC25 values of both Sal and AgNPs (3.0 µM and 4 µg/mL), which showed a more dramatic inhibitory effect on cell viability and cell morphology than either Sal or AgNPs alone. The combination of Sal and AgNPs had more pronounced effect on cytotoxicity and expression of apoptotic genes and also significantly induced the accumulation of autophagolysosomes, which was associated with mitochondrial dysfunction and loss of cell viability. Our data show a strong synergistic interaction between Sal and AgNPs in tested cancer cells. The combination treatment increased the therapeutic potential and demonstrated the relevant targeted therapy for the treatment of ovarian cancer. Furthermore, we provide, for the first time, a mode of action for Sal and AgNPs in ovarian cancer cells: enhanced apoptosis and autophagy.

Keywords: apoptosis, autophagy, cell viability, caspase activity, ovarian cancer, salinomycin, silver nanoparticles

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Novel biomolecule lycopene-reduced graphene oxide-silver nanoparticle enhances apoptotic potential of trichostatin A in human ovarian cancer cells (SKOV3)

Zhang XF, Huang FH, Zhang GL, Bai DP, Massimo DF, Huang YF, Gurunathan S

International Journal of Nanomedicine 2017, 12:7551-7575

Published Date: 13 October 2017

Zinc oxide nanoparticles induce apoptosis and autophagy in human ovarian cancer cells

Bai D, Zhang X, Zhang G, Huang Y, Gurunathan S

International Journal of Nanomedicine 2017, 12:6521-6535

Published Date: 5 September 2017

Silver nanoparticles cause complications in pregnant mice

Zhang XF, Park JH, Choi YJ, Kang MH, Gurunathan S, Kim JH

International Journal of Nanomedicine 2015, 10:7057-7071

Published Date: 13 November 2015

Effects of silver nanoparticles on neonatal testis development in mice

Zhang XF, Gurunathan S, Kim JH,

International Journal of Nanomedicine 2015, 10:6243-6256

Published Date: 5 October 2015

Reduced graphene oxide–silver nanoparticle nanocomposite: a potential anticancer nanotherapy

Gurunathan S, Han JW, Park JH, Kim E, Choi YJ, Kwon DN, Kim JH

International Journal of Nanomedicine 2015, 10:6257-6276

Published Date: 5 October 2015

Differential nanoreprotoxicity of silver nanoparticles in male somatic cells and spermatogonial stem cells

Zhang XF, Choi YJ, Han JW, Kim ES, Park JH, Gurunathan S, Kim JH

International Journal of Nanomedicine 2015, 10:1335-1357

Published Date: 16 February 2015

An in vitro evaluation of graphene oxide reduced by Ganoderma spp. in human breast cancer cells (MDA-MB-231)

Gurunathan S, Han J, Park JH, Kim JH

International Journal of Nanomedicine 2014, 9:1783-1797

Published Date: 8 April 2014

Ginkgo biloba: a natural reducing agent for the synthesis of cytocompatible graphene

Gurunathan S, Han JW, Park JH, Eppakayala V, Kim JH

International Journal of Nanomedicine 2014, 9:363-377

Published Date: 7 January 2014

Green chemistry approach for the synthesis of biocompatible graphene

Gurunathan S, Han JW, Kim JH

International Journal of Nanomedicine 2013, 8:2719-2732

Published Date: 31 July 2013

Green synthesis of graphene and its cytotoxic effects in human breast cancer cells

Gurunathan S, Han JW, Eppakayala V, Kim JH

International Journal of Nanomedicine 2013, 8:1015-1027

Published Date: 10 March 2013

Oxidative stress-mediated antibacterial activity of graphene oxide and reduced graphene oxide in Pseudomonas aeruginosa

Gurunathan S, Han JW, Dayem AA, Eppakayala V, Kim JH

International Journal of Nanomedicine 2012, 7:5901-5914

Published Date: 30 November 2012

Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model

Muthu Irulappan Sriram, Selvaraj Barath Mani Kanth, Kalimuthu Kalishwaralal, et al

International Journal of Nanomedicine 2010, 5:753-762

Published Date: 24 September 2010